Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Topical Ruxolitinib may safely treat severe hair loss.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

The new wound dressing improves healing and tissue repair better than conventional dressings.

The gel effectively reduced folliculitis symptoms and was safe to use.

Tofacitinib helped a woman regrow hair with no major side effects.

Urotensin II increases growth and VEGF production in rat skin cells by turning on the Wnt-β-catenin pathway.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Illicium anisatum extract may boost hair growth.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.